Changes in serum markers of oxidative stress with varying periods of haemodialysis

被引:36
作者
Köken, T
Serteser, M
Kahraman, A
Gökçe, Ç
Demir, S
机构
[1] Afyon Kocatepe Univ, Fac Med, Dept Biochem & Clin Biochem, TR-03200 Afyon, Turkey
[2] Afyon Kocatepe Univ, Fac Med, Div Nephrol, Dept Internal Med, TR-03200 Afyon, Turkey
关键词
haemodialysis; oxidative stress; protein carbonyls; renal failure; sulfhydryl; thiobarbituric acid reactive substances; uraemia;
D O I
10.1111/j.1440-1797.2004.00240.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background and Aims: Oxidative stress possibly helps promote the progression and complications of chronic renal failure (CRF). Haemodialysis (HD) may aggravate oxidative stress. This controlled, cross-sectional clinical study with blind outcome assessment evaluated the effect of prolonged HD treatment on oxidative stress. Methods and Results: Seventy patients (M/F = 33/37) with CRF and who were on HD were divided into six groups with differing treatment periods of HD; from 3 to 12 months to 85-120 months. Twelve healthy subjects acted as controls. The serum levels of thiobarbituric acid reactive substances (TBARS), total sulfhydryl (SH) groups and protein carbonyls (PCs) were determined. Compared with controls, PCs were increased in patients, and this positively correlated with the duration of HD. Treatment for more than 24 months caused the most striking increases in PCs, with relevant differences as compared to those on HD for a maximum of 12 months. Increasing periods of HD were associated with increases in TBARS and similar decreases in SH as compared with controls; the differences between the SH levels of those on HD for more than 84 months and those on HD for up to 24 months were significant. Conclusion: Our results indicate that HD continued for more than 2 years aggravates the latter. Decreased potential for oxygen-radical-scavenger activity becomes pronounced after 7 years of HD treatment.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 42 条
[1]
ROLE OF FREE-RADICALS IN CANCER AND ATHEROSCLEROSIS [J].
BANKSON, DD ;
KESTIN, M ;
RIFAI, N .
CLINICS IN LABORATORY MEDICINE, 1993, 13 (02) :463-480
[2]
Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure [J].
CeballosPicot, I ;
WitkoSarsat, V ;
MeradBoudia, M ;
Nguyen, AT ;
Thevenin, M ;
Jaudon, MC ;
Zingraff, J ;
Verger, C ;
Jungers, P ;
DescampsLatscha, B .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 21 (06) :845-853
[3]
CERUTTI PA, 1991, CANCER CELL-MON REV, V3, P1
[4]
Chevion M, 2000, FREE RADICAL RES, V33, pS99
[5]
Donate Teresa, 2002, Adv Perit Dial, V18, P15
[6]
Free radicals in the physiological control of cell function [J].
Dröge, W .
PHYSIOLOGICAL REVIEWS, 2002, 82 (01) :47-95
[7]
Blood oxidant/antioxidant status of atherosclerotic patients [J].
Durak, I ;
Kaçmaz, M ;
Çimen, MYB ;
Büyükkoçak, Ü ;
Öztürk, HS .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2001, 77 (2-3) :293-297
[8]
LOW PLATELET GLUTATHIONE-PEROXIDASE ACTIVITY AND SERUM SELENIUM CONCENTRATION IN PATIENTS WITH CHRONIC-RENAL-FAILURE - RELATIONS TO DIALYSIS TREATMENTS, DIET AND CARDIOVASCULAR COMPLICATIONS [J].
GIRELLI, D ;
OLIVIERI, O ;
STANZIAL, AM ;
AZZINI, M ;
LUPO, A ;
BERNICH, P ;
MENINI, C ;
GAMMARO, L ;
CORROCHER, R .
CLINICAL SCIENCE, 1993, 84 (06) :611-617
[9]
GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819
[10]
Plasma protein thiol oxidation and carbonyl formation in chronic renal failure [J].
Himmelfarb, J ;
McMonagle, E ;
McMenamin, E .
KIDNEY INTERNATIONAL, 2000, 58 (06) :2571-2578